1.1 A bill for an act
1.2 relating to human services; directing commissioner of human services to establish
1.3 a prescription drug purchasing program; specifying program authority and eligibility
1.4 requirements; requiring recommendations; proposing coding for new law in
1.5 Minnesota Statutes, chapter 256B.
1.6BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.7 Section 1. [256B.86] PRESCRIPTION DRUG PURCHASING PROGRAM.
1.8 Subdivision 1.Establishment of program.(a) The commissioner of human services
1.9shall administer and oversee a prescription drug purchasing program for prescription drugs
1.10provided to program participants.
1.11 (b) For purposes of this section, "program participants" means medical assistance and
1.12MinnesotaCare enrollees served under the fee-for-service and managed care delivery systems.
1.13 Subd. 2.Duties of commissioner.The commissioner, through the prescription drug
1.14purchasing program, shall:
1.15 (1) obtain prescription drugs for program participants at the lowest possible prices;
1.16 (2) promote health through the purchase and provision of discounted prescription drugs
1.17and coordination of comprehensive prescription benefit services for program participants;
1.18 (3) maintain a list of prescription drugs recommended as the most effective prescription
1.19drugs available at the best possible prices;
1.20 (4) administer prescription drug benefits for medical assistance and MinnesotaCare; and
1.21 (5) adjudicate pharmacy claims and transmit program prices and other information to
1.22pharmacies.
1Section 1.
REVISOR AGW/EN 25-0277002/07/25
State of Minnesota
This Document can be made available
in alternative formats upon request
HOUSE OF REPRESENTATIVES
H. F. No. 1093
NINETY-FOURTH SESSION
Authored by Liebling and Bierman02/17/2025
The bill was read for the first time and referred to the Committee on Human Services Finance and Policy 2.1 Subd. 3.Program authority.(a) To accomplish the purposes of the prescription drug
2.2purchasing program, the commissioner, in consultation with the Formulary Committee
2.3established under section 256B.0625, subdivision 13c, has the authority to:
2.4 (1) adopt or develop a preferred drug list;
2.5 (2) engage in price negotiations with prescription drug manufacturers, wholesalers, or
2.6group purchasing organizations to obtain price discounts and rebates for prescription drugs
2.7for program participants; and
2.8 (3) develop and manage a drug formulary for the program.
2.9 (b) The commissioner may contract with one or more entities to perform any of the
2.10functions described in paragraph (a) but must not shift risk to a nongovernmental entity
2.11without specific authorization by law.
2.12 Subd. 4.Pharmacies.The commissioner shall set the terms and conditions for pharmacies
2.13to participate in the program. The commissioner shall enroll all pharmacies participating
2.14as medical assistance providers, and any other pharmacy licensed under chapter 151 willing
2.15to accept the terms and conditions, in the program.
2.16 Subd. 5.Federal approval.The commissioner shall seek any necessary federal approvals
2.17to implement this section.
2.18 EFFECTIVE DATE.This section is effective January 1, 2027, or upon federal approval,
2.19whichever is later, except that subdivision 5 is effective the day following final enactment.
2.20The commissioner of human services shall notify the revisor of statutes when federal approval
2.21is obtained.
2.22 Sec. 2. EXPANSION OF PRESCRIPTION DRUG PURCHASING PROGRAM.
2.23 The commissioner of human services, in consultation with the commissioners of
2.24commerce and health, shall develop recommendations for expanding the prescription drug
2.25purchasing program established under Minnesota Statutes, section 256B.86, to include
2.26enrollees of health plan companies that have contracted with the commissioner to participate
2.27in the program. The recommendations must address the process and terms by which the
2.28commissioner would contract with health plan companies to administer prescription drug
2.29benefits and develop and manage a drug formulary. The commissioner shall present
2.30recommendations to the chairs and ranking minority members of the legislative committees
2.31with jurisdiction over commerce and health and human services finance and policy by
2.32December 15, 2027.
2Sec. 2.
REVISOR AGW/EN 25-0277002/07/25